Modification of Prescription Drug Event (PDE) editing of Cialis for Benign Prostatic Hyperplasia (BPH)
Guidance for CMS has become aware of PDEs being accepted for dosing below 1 tablet per day at the 5 mg strength or 2 tablets per day at the 2.5 mg strength which does not correspond with the treatment of BPH. In response, the editing for PDEs for Cialis is being modified.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: August 02, 2013
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.